Monthly Archives: March 2014
Sarah Chapple defends organ and tissue donation after cardiac death for patients who are critically ill and dependent on mechanical ventilation, but who do not meet the requirements for neurological death.
Scott Findlay argues for evidence-informed decision-making, on the basis of which the federal government should grant the Dr. Peter Centre in Vancouver an exemption to Canada’s Controlled Drugs and Substances Act so that clients can continue to receive supervised injection services.
Leigh Turner continues to question in the face of silence.
Kat Lanteigne argues that there are no good reasons for Canadians to be in the business of buying and selling blood.
Kirstin Borgerson explains why audiences presented with the facts in the Markingson case react with silence, and offers some thoughts on how bioethicists might break that silence.
Leigh Turner continues to call for an independent investigation of research practices at the University of Minnesota and the death of Dan Markingson.
Melissa Haussman suggests that Health Canada’s recent deliberations on the licensing of RU-486 are reminiscent of foot-dragging politics in the US.